ACC-006

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameACC-006
Drug Alias Name艾索康唑2S,4R-itraconazoleaisuokangzuo3羟基-伊曲康唑ACC-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitorsSonic Hedgehog Homolog inhibitors
TargetsSerine/threonine-protein kinase mTORSonic Hedgehog Homolog
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co LtdChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Accelas Pharmaceutical Co LtdJiangsu Aidea Pharmaceutical Group Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A